SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently facing significant volatility driven by a combination of geopolitical tensions, including concerns over Middle Eastern supply chains, and legal headwinds stemming from a jury verdict regarding past investor disclosures. Market participants are actively debating the company's long-term outlook, with discussion focused on the potential impact of high-cost 'Terafab' infrastructure plans on future profitability versus the long-term potential of its AI and robotics initiatives.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors and community members express significant apprehension regarding the escalating geopolitical conflict in the Middle East and its potential impact on the broader market. Discussion is dominated by heated debates over the administration's foreign policy, concerns about rising energy costs, and widespread skepticism regarding the company's long-term stability amidst ongoing market volatility.

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

AleAnna is surging as a primary beneficiary of the ongoing Middle East energy crisis, with the community closely tracking the potential for a massive short squeeze driven by extremely low float and record-breaking volume. Investors are hyper-focused on the company's natural gas assets in Italy as a critical energy security play, while the message boards are buzzing with intense debate over potential warrant exercises and whether the stock's momentum can mirror past sector runners.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is experiencing heightened volatility as market participants react to the escalating geopolitical tensions involving the U.S. and Iran, specifically centered on threats to the Strait of Hormuz. The community is sharply divided, with intense debate ongoing regarding the potential for an immediate resolution versus a prolonged conflict, while traders closely monitor oil prices and institutional hedging as indicators for the next market trend.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund (USO) is trending as geopolitical volatility in the Middle East intensifies following a high-stakes 48-hour ultimatum by the U.S. regarding the Strait of Hormuz. The community is actively debating whether energy prices will continue to spike due to potential supply infrastructure disruptions or if the market has already reached a short-term peak as diplomatic chatter and military deployment news create deep uncertainty.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending as investors weigh strong China smartphone sales against broader market concerns over stagflation, geopolitical volatility in the Middle East, and the potential impact of interest rate uncertainty on tech valuations. While some in the community highlight the firm's resilient hardware ecosystem and AI-driven growth potential, many are actively debating the stock's recent underperformance and technical breakdown, with traders focused on critical support levels near the 200-day moving average.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Markets are exhibiting heightened volatility as traders weigh a time-sensitive ultimatum issued to Iran regarding the Strait of Hormuz against fears of a deepening global energy crisis. The community is actively debating the potential for a sharp corrective pullback in tech-heavy indices while speculating on whether ongoing diplomatic maneuvers will result in a rapid de-escalation or a sustained economic downturn.

Coeur Mining, Inc. engages in the well-diversified, growing precious metals producer with a focus on generating sustainable, high-quality cash flow and returns from a balanced, prospective asset base in mining-friendly jurisdictions along with commitment to exploration and expansions. It operates through the following segments: Palmarejo, Rochester, Kensington, Wharf and Silvertip. The Palmarejo segment includes a gold-silver complex. The Rochester segment operates an open pit heap leach silver-gold mine in northwestern Nevada. The Kensington segment relates to an underground gold mine located north of Juneau, Alaska. The Wharf segment focuses on an open pit heap leach gold mine located near Lead, South Dakota. The Silvertip segment silver-zinc-lead exploration located in the state of Sonora in northern Mexico. The company was founded in 1928 and is headquartered in Chicago, IL.

Coeur Mining Inc

Coeur Mining is currently at the center of investor focus following its recent merger with New Gold, as the market weighs the company's significantly expanded production profile against ongoing volatility in silver and gold prices. While community members are actively debating the long-term potential of the deal, traders remain sharply divided, with many monitoring short-interest levels and technical support zones in anticipation of the upcoming earnings report.

Select Sector SPDR Trust (The) - State Street Financial Select Sector SPDR ETF

Financial Select Sector SPDR Fund

The Financial Select Sector SPDR Fund (XLF) is currently trending as investors rotate capital into financials and industrials while monitoring interest rate policy and sector-wide bank earnings. Community discussions focus on the fund's resilience amidst broader market volatility, with many traders closely watching key technical support levels and institutional rotation patterns as potential indicators for the next market move.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is experiencing intense volatility and downward pressure as investors abandon the metal amid a strengthening dollar and surging bond yields. The community is sharply divided, with many debating whether this is a structural failure of gold's safe-haven narrative or a massive liquidity flush offering a generational buying opportunity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Given Consensus Recommendation of "Reduce" by Brokerages

Shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX - Get Free Report) have earned an average rating of "Reduce" from the five analysts that are currently covering the company, Marketbeat reports. Two research analysts have rated the stock with a sell rating, two have given a hold rating and one has...

Canaccord Genuity Group Issues Pessimistic Forecast for Pliant Therapeutics (NASDAQ:PLRX) Stock Price

Canaccord Genuity Group lowered their price target on Pliant Therapeutics from $4.00 to $3.00 and set a "hold" rating for the company in a research note on Friday...

Pliant Therapeutics (NASDAQ:PLRX) Issues Quarterly Earnings Results

Pliant Therapeutics (NASDAQ:PLRX - Get Free Report) announced its quarterly earnings data on Wednesday. The company reported ($0.38) earnings per share (EPS) for the quarter, topping the consensus...

Pliant Therapeutics Pivots to Oncology, Highlights Early PLN-101095 Responses at Oppenheimer Conference

Pliant Therapeutics (NASDAQ:PLRX) used its presentation at Oppenheimer's 36th Annual Healthcare Conference to outline its strategic transition toward oncology following the discontinuation of its...

Pliant Therapeutics (PLRX) Expected to Announce Quarterly Earnings on Monday

Pliant Therapeutics (NASDAQ:PLRX) will be releasing its Q4 2025 earnings before the market opens on Monday, March 2. (View Earnings Report at...

Pliant Therapeutics (NASDAQ:PLRX) CEO Sells $114,400.00 in Stock

Pliant Therapeutics, Inc. (NASDAQ:PLRX - Get Free Report) CEO Bernard Coulie sold 89,375 shares of the business's stock in a transaction that occurred on Tuesday, January 20th. The stock was sold at...

Bernard Coulie Sells 89,375 Shares of Pliant Therapeutics (NASDAQ:PLRX) Stock

Pliant Therapeutics, Inc. (NASDAQ:PLRX - Get Free Report) CEO Bernard Coulie sold 89,375 shares of the firm's stock in a transaction on Tuesday, January 20th. The stock was sold at an average price...

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Given Average Rating of "Reduce" by Analysts

Pliant Therapeutics, Inc. (NASDAQ:PLRX - Get Free Report) has been assigned an average recommendation of "Reduce" from the fourteen ratings firms that are currently covering the stock, MarketBeat...

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Short Interest Down 20.3% in December

Pliant Therapeutics, Inc. (NASDAQ:PLRX - Get Free Report) was the target of a large decline in short interest during the month of December. As of December 15th, there was short interest totaling...

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Given Average Rating of "Reduce" by Brokerages

Pliant Therapeutics, Inc. (NASDAQ:PLRX - Get Free Report) has earned a consensus rating of "Reduce" from the fourteen ratings firms that are currently covering the firm, MarketBeat reports. Two...

Pliant Therapeutics, Inc. engages in the discovery, development and commercialization of therapies for fibrotic diseases. It offers a product discovery engine. The company is pursuing drug development programs for a range of fibrotic diseases, focusing on tissue-specific integrin modulation and TGF-ß1 signaling inhibition. The company was founded by Bradley Backes, Bill De Grado, Hal Chapman, and Dean Sheppard in June 2015 and is headquartered in South San Francisco, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.36	--	--	N/A
Q4 '25	-$0.38	-$0.38	-0.36%	MISSED
Q3 '25	-$0.52	-$0.43	17.97%	BEAT
Q2 '25	-$0.68	-$0.71	-4.85%	MISSED
Q1 '25	-$0.77	-$0.92	-19.98%	MISSED

PLRX
Pliant Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest PLRX News

PLRXPliant Therapeutics Inc